Around the Net
U.S. FDA Warns AstraZeneca Over Breast-Cancer Ads (Reuters)
United States regulators have told AstraZeneca (AZN) that the Anglo-Swedish drug maker has to stop running what it called "misleading" ads for breast-cancer drug Nolvadex.
